Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (2): 312-315    DOI: 10.12891/ceog4029.2018
Case Report Previous articles | Next articles
Confirmation of menopause based on changes in follicle-stimulating hormone levels in patients who were administered dienogest
H. Takagi1, *(), T. Sasagawa1, Y. Osaka1
1 Department of Obstetrics and Gynecology, Kanazawa Medical University, School of Medicine, Uchinada, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: The appropriate time for patients to discontinue dienogest (DNG) after long-term use has been a recent topic of debate. Therefore, this study evaluated the timing for discontinuation of DNG in climacteric patients suffering from endometriosis and adenomyosis. Materials and Methods: DNG was orally administered at 2 mg/day for more than 12 months. The serum estradiol (E2) and follicle-stimulating hormone (FSH) levels were measured every three to six months. DNG was discontinued when the hormone levels changed to those characteristic of menopause. Results: FSH levels in three patients increased to more than 25.8 mIU/mL during DNG administration. They were thus diagnosed as having entered menopause. There was no recurrence of pain in these patients at one year after discontinuation of DNG. Conclusion: An increase in serum FSH levels could help in confirming the diagnosis of menopause. In addition, DNG prevented the recurrence of endometriosis and adenomyosis.
Key words:  Dienogest      Endometriosis      Adenomyosis      Estradiol      Follicle-stimulating hormone     
Published:  10 April 2018     
*Corresponding Author(s):  H. TAKAGI     E-mail:  terry-1@kanazawa-med.ac.jp

Cite this article: 

H. Takagi, T. Sasagawa, Y. Osaka. Confirmation of menopause based on changes in follicle-stimulating hormone levels in patients who were administered dienogest. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 312-315.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4029.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I2/312

[1] Anjeza Xholli, Anna Biasioli, Giovanni Grandi, Angelo Cagnacci. Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1186-1192.
[2] Jian-Zhong Pan, Yan Tang, Ling Li, Xin-Yue Xu, Xiao Cheng, Yuan-Yuan Chen. “Umbilical mass”: a case of primary umbilical endometriosis and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1227-1231.
[3] Sayuli Bhide, Rebecca Flyckt, Meng Yao, Tommaso Falcone. Long-term impact of chronic pelvic pain on quality of life in women with and without endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 851-859.
[4] Aybike Pekin, Ayşe Gül Kebapçılar, Ersin Çintesun, Setenay Arzu Yılmaz, Özlem Seçilmiş Kerimoğlu. Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 924-928.
[5] Xi-Wa Zhao, Meng-Meng Zhang, Jian Zhao, Wei Zhao, Shan Kang. Correlative factors associated with the recurrence of ovarian endometriosis: a retrospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 962-968.
[6] Engin Turkgeldi, Sule Yildiz, Berk Angun, Bulent Urman, Baris Ata. Oocyte yield of GnRH antagonist cycles scheduled with a short course of estradiol in the early follicular phase[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 278-282.
[7] Su-Xian Zhang, Lu Wu, You-Fang Hou, Bo Yan, Shao-Yan Yang, Li-Hua Yang, Qing-Hua Zhao. Hemoperitoneum caused by bleeding of adenomyosis: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 444-447.
[8] Ja Young Kim, Yun Gyu Song, Chang-Woon Kim, Moon Ok Lee. Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 59-65.
[9] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[10] Xiao Zhang, Ying-Ying He, Nan Jiang, Zhi-Gang Sun, Feng Yan, Cidanyangzong, Fang Long, Fang-Xin Shi, Xiao-Guang Xu, Zhen Xiao. The infiltrating ability of abdominal wall endometriosis is associated with ectopic endometrial glandular activity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 73-78.
[11] Yan-Bing Xiao, Meng Mou, Heng-Fang Gu, Hui-Xing Li, Meng-Yuan You, Zhi-Gang Liang, Lei Han. The impact of major uterine wall resection and reconstruction of the uterus (MURU) on uterine hemodynamics and ovarian function in patients with adenomyosis: a clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 132-137.
[12] Masataka Ono, Junya Kojima, Ei Hasegawa, Yotaro Takaesu, Toru Sasaki, Hirotaka Nishi. Anti-Müllerian hormone levels following laparoscopic ovarian cystectomy with subcutaneous abdominal wall lifting for ovarian endometriomas[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 91-97.
[13] I. Thanaboonyawat, P. Chera-aree, S. Petyim, R. Choavaratana, P. Laokirkkiat. The effect of three-month topical testosterone gel application on semen quality in men with oligozoospermia and low serum testosterone levels[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 875-881.
[14] D. Filipecka-Tyczka, A. Kajdy, B.P. Siekierski, M. Stańczyk, A. Rogowski, M. Rabijewski, R.B. Maksym. Deep infiltrating endometriosis as a cause of severe urogynecological complications despite invasive treatment - report of two cases from the center of endometriosis surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 955-960.
[15] S.Y. Song, G.W. Lee, J.B. Yang, D.E. Kim, D.B. Park, H.J. Yoo. Septic shock caused by abscess formation inside cystic adenomyosis after responsive treatment of pelvic inflammatory disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 983-987.
No Suggested Reading articles found!